Expanded Access to Navitoclax

NCT03592576 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Myelofibrosis
Acute Lymphocytic Leukemia (ALL)
Lymphoblastic Lymphoma

Interventions

DRUG: Navitoclax
DRUG: Venetoclax

Sponsor

AbbVie